February 2022 - FDA Takes New Steps to Stimulate Development of Non-Opioids in Acute Pain Management

FDA Takes New Steps to Stimulate Development of Non-Opioids in Acute Pain Management
Read more
April 2021 - SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

April 2021 - SentryX closes €3.2M seed funding round for the development of next generation pain relief therapeutics

SentryX, a spin-off of the University Medical Center Utrecht (the Netherlands) today announced that it raised €3.2M in seed funding for the development of their next-generation pain relief therapeutic platform.
Read more